Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been given an average rating of “Hold” by the fourteen analysts that are currently covering the stock, MarketBeat reports. Two investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback